Bayer Expounds Emerging Markets Strategy

Our leading long-term core view for the pharmaceuticals and healthcare industry is that emerging markets will drive industry growth. Sales of medical services in developed states are forecast to plateau over the next decade, mainly as result of government cost-containment measures and the 2011-2013 patent cliff.

To read the full article, please choose one of the following options: